Centiva Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.88M | Buy |
14,505
+3,150
| +28% | +$1.28M | 0.1% | 38 |
|
|
2025
Q1 | $5.65M | Buy |
11,355
+5,109
| +82% | +$2.54M | 0.17% | 21 |
|
|
2024
Q4 | $3.25M | Sell |
6,246
-4,293
| -41% | -$2.23M | 0.07% | 75 |
|
|
2024
Q3 | $6.52M | Sell |
10,539
-13,855
| -57% | -$8.57M | 0.13% | 46 |
|
|
2024
Q2 | $13.5M | Buy |
24,394
+22,287
| +1,058% | +$12.3M | 0.23% | 20 |
|
|
2024
Q1 | $1.22M | Buy |
+2,107
| New | +$1.22M | 0.03% | 344 |
|
|
2023
Q4 | – | Sell |
-8,672
| Closed | -$4.39M | – | 1648 |
|
|
2023
Q3 | $4.39M | Sell |
8,672
-9,554
| -52% | -$4.84M | 0.1% | 78 |
|
|
2023
Q2 | $9.51M | Buy |
+18,226
| New | +$9.51M | 0.21% | 25 |
|
|
2023
Q1 | – | Sell |
-1,191
| Closed | -$656K | – | 1344 |
|
|
2022
Q4 | $656K | Buy |
1,191
+973
| +446% | +$536K | 0.02% | 395 |
|
|
2022
Q3 | $111K | Sell |
218
-875
| -80% | -$446K | ﹤0.01% | 806 |
|
|
2022
Q2 | $594K | Sell |
1,093
-3,165
| -74% | -$1.72M | 0.01% | 559 |
|
|
2022
Q1 | $2.52M | Buy |
4,258
+120
| +3% | +$70.9K | 0.05% | 175 |
|
|
2021
Q4 | $2.76M | Buy |
4,138
+3,650
| +748% | +$2.44M | 0.06% | 120 |
|
|
2021
Q3 | $279K | Sell |
488
-424
| -46% | -$242K | 0.02% | 644 |
|
|
2021
Q2 | $460K | Buy |
+912
| New | +$460K | 0.01% | 573 |
|
|
2020
Q4 | – | Sell |
-2,851
| Closed | -$1.26M | – | 906 |
|
|
2020
Q3 | $1.26M | Buy |
2,851
+571
| +25% | +$252K | 0.08% | 93 |
|
|
2020
Q2 | $826K | Buy |
2,280
+1,683
| +282% | +$610K | 0.05% | 114 |
|
|
2020
Q1 | $169K | Sell |
597
-1,009
| -63% | -$286K | 0.01% | 269 |
|
|
2019
Q4 | $522K | Buy |
+1,606
| New | +$522K | 0.03% | 181 |
|